274 related articles for article (PubMed ID: 32071205)
1. The MYCL and MXD1 transcription factors regulate the fitness of murine dendritic cells.
Anderson DA; Murphy TL; Eisenman RN; Murphy KM
Proc Natl Acad Sci U S A; 2020 Mar; 117(9):4885-4893. PubMed ID: 32071205
[TBL] [Abstract][Full Text] [Related]
2. Targeting miR-21 with NL101 blocks c-Myc/Mxd1 loop and inhibits the growth of B cell lymphoma.
Li S; He X; Gan Y; Zhang J; Gao F; Lin L; Qiu X; Yu T; Zhang X; Chen P; Tong J; Qian W; Xu Y
Theranostics; 2021; 11(7):3439-3451. PubMed ID: 33537096
[No Abstract] [Full Text] [Related]
3. Vitamin D receptor as a master regulator of the c-MYC/MXD1 network.
Salehi-Tabar R; Nguyen-Yamamoto L; Tavera-Mendoza LE; Quail T; Dimitrov V; An BS; Glass L; Goltzman D; White JH
Proc Natl Acad Sci U S A; 2012 Nov; 109(46):18827-32. PubMed ID: 23112173
[TBL] [Abstract][Full Text] [Related]
4. Functional interactions among members of the MAX and MLX transcriptional network during oncogenesis.
Diolaiti D; McFerrin L; Carroll PA; Eisenman RN
Biochim Biophys Acta; 2015 May; 1849(5):484-500. PubMed ID: 24857747
[TBL] [Abstract][Full Text] [Related]
5. Of Myc and Mnt.
Hooker CW; Hurlin PJ
J Cell Sci; 2006 Jan; 119(Pt 2):208-16. PubMed ID: 16410546
[TBL] [Abstract][Full Text] [Related]
6. Elucidation of the structural determinants responsible for the specific formation of heterodimeric Mxd1/Max b-HLH-LZ and its binding to E-box sequences.
Montagne M; Naud JF; Lavigne P
J Mol Biol; 2008 Feb; 376(1):141-52. PubMed ID: 18155722
[TBL] [Abstract][Full Text] [Related]
7. Structural aspects of interactions within the Myc/Max/Mad network.
Nair SK; Burley SK
Curr Top Microbiol Immunol; 2006; 302():123-43. PubMed ID: 16620027
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional regulation. Flipping the Myc switch.
Bernards R
Curr Biol; 1995 Aug; 5(8):859-61. PubMed ID: 7583141
[TBL] [Abstract][Full Text] [Related]
9.
Theisen DJ; Ferris ST; Briseño CG; Kretzer N; Iwata A; Murphy KM; Murphy TL
Cancer Immunol Res; 2019 Jan; 7(1):29-39. PubMed ID: 30482745
[TBL] [Abstract][Full Text] [Related]
10. MiR-19a/b modulate the metastasis of gastric cancer cells by targeting the tumour suppressor MXD1.
Wu Q; Yang Z; An Y; Hu H; Yin J; Zhang P; Nie Y; Wu K; Shi Y; Fan D
Cell Death Dis; 2014 Mar; 5(3):e1144. PubMed ID: 24675462
[TBL] [Abstract][Full Text] [Related]
11. An MXD1-derived repressor peptide identifies noncoding mediators of MYC-driven cell proliferation.
Raffeiner P; Hart JR; García-Caballero D; Bar-Peled L; Weinberg MS; Vogt PK
Proc Natl Acad Sci U S A; 2020 Mar; 117(12):6571-6579. PubMed ID: 32156728
[TBL] [Abstract][Full Text] [Related]
12. Down regulation of miR-202 modulates Mxd1 and Sin3A repressor complexes to induce apoptosis of pancreatic cancer cells.
Farhana L; Dawson MI; Fontana JA
Cancer Biol Ther; 2015; 16(1):115-24. PubMed ID: 25611699
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the Myc and Max interaction specificity with lambda repressor-HLH domain fusions.
Marchetti A; Abril-Marti M; Illi B; Cesareni G; Nasi S
J Mol Biol; 1995 May; 248(3):541-50. PubMed ID: 7752223
[TBL] [Abstract][Full Text] [Related]
14. DNGR-1 limits Flt3L-mediated antitumor immunity by restraining tumor-infiltrating type I conventional dendritic cells.
Cueto FJ; Del Fresno C; Brandi P; Combes AJ; Hernández-García E; Sánchez-Paulete AR; Enamorado M; Bromley CP; Gomez MJ; Conde-Garrosa R; Mañes S; Zelenay S; Melero I; Iborra S; Krummel MF; Sancho D
J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 33980589
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Myc transcriptional activity by a mini-protein based upon Mxd1.
Demma MJ; Hohn MJ; Sun A; Mapelli C; Hall B; Walji A; O'Neil J
FEBS Lett; 2020 May; 594(10):1467-1476. PubMed ID: 32053209
[TBL] [Abstract][Full Text] [Related]
16. MAGI2-AS3 suppresses MYC signaling to inhibit cell proliferation and migration in ovarian cancer through targeting miR-525-5p/MXD1 axis.
Chang H; Zhang X; Li B; Meng X
Cancer Med; 2020 Sep; 9(17):6377-6386. PubMed ID: 32681706
[TBL] [Abstract][Full Text] [Related]
17. Stabilization of the Max Homodimer with a Small Molecule Attenuates Myc-Driven Transcription.
Struntz NB; Chen A; Deutzmann A; Wilson RM; Stefan E; Evans HL; Ramirez MA; Liang T; Caballero F; Wildschut MHE; Neel DV; Freeman DB; Pop MS; McConkey M; Muller S; Curtin BH; Tseng H; Frombach KR; Butty VL; Levine SS; Feau C; Elmiligy S; Hong JA; Lewis TA; Vetere A; Clemons PA; Malstrom SE; Ebert BL; Lin CY; Felsher DW; Koehler AN
Cell Chem Biol; 2019 May; 26(5):711-723.e14. PubMed ID: 30880155
[TBL] [Abstract][Full Text] [Related]
18. Myc interacts with Max and Miz1 to repress C/EBPdelta promoter activity and gene expression.
Si J; Yu X; Zhang Y; DeWille JW
Mol Cancer; 2010 Apr; 9():92. PubMed ID: 20426839
[TBL] [Abstract][Full Text] [Related]
19. A dynamic exchange of TCF3 and TCF4 transcription factors controls MYC expression in colorectal cancer cells.
Shah M; Rennoll SA; Raup-Konsavage WM; Yochum GS
Cell Cycle; 2015; 14(3):323-32. PubMed ID: 25659031
[TBL] [Abstract][Full Text] [Related]
20. Normal and Neoplastic Growth Suppression by the Extended Myc Network.
Prochownik EV; Wang H
Cells; 2022 Feb; 11(4):. PubMed ID: 35203395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
